Free Trial

Xilio Therapeutics (XLO) Earnings Date, Estimates & Call Transcripts

Xilio Therapeutics logo
$0.88 0.00 (-0.43%)
Closing price 05/27/2025 04:00 PM Eastern
Extended Trading
$0.88 0.00 (-0.45%)
As of 05/27/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Xilio Therapeutics Earnings Summary

Xilio Therapeutics announced Q1 2025 earnings on May 13, 2025, reporting an EPS of -$0.18, which missed the consensus estimate of $0.10 by $0.28. Quarterly revenue was reported to be $2.93 million, below analyst estimates of $42 million. With a trailing EPS of -$0.84, Xilio Therapeutics' earnings are expected to grow next year, from ($1.14) to ($0.40) per share.

Upcoming Q2
Earnings Date
Aug. 14Before Market OpensEstimated
Consensus EPS
(May. 13)
$0.10
Actual EPS
(May. 13)
-$0.18 Missed By -$0.28
Actual Revenue
(May. 13)
$2.93M

Q1 2025 Earnings Resources

XLO Upcoming Earnings

Xilio Therapeutics' next earnings date is estimated for Thursday, August 14, 2025, based on past reporting schedules.

Get Xilio Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Xilio Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

XLO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

XLO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Xilio Therapeutics Analyst EPS Estimates

Current Year EPS Consensus Estimate
($1.14) EPS
Next Year EPS Consensus Estimate
($0.40) EPS

Xilio Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/14/2025
(Estimated)
--------
5/13/2025Q1 2025$0.10-$0.18 -$0.28-$0.18$42.00M$2.93M
3/11/2025Q4 2024-$0.22-$0.20+$0.02-$0.20$2.26M$1.72M
11/7/2024--$0.25-$0.22+$0.03-$0.22--
8/8/2024--$0.23-$0.24 -$0.01-$0.24$30.00M$2.36M
5/14/2024Q1 2024-$0.30-$0.59 -$0.29-$0.56--
4/1/2024Q4 2023--$0.64 -$0.64-$0.64--
11/9/2023Q3 2023-$0.76-$0.61+$0.15-$0.61--
8/14/2023Q2 2023-$0.84-$0.70+$0.14-$0.70--

Xilio Therapeutics Earnings - Frequently Asked Questions

Xilio Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 14th, 2025 based off last year's report dates. Learn more on XLO's earnings history.

In the previous quarter, Xilio Therapeutics (NASDAQ:XLO) missed the analysts' consensus estimate of $0.10 by $0.28 with a reported earnings per share (EPS) of ($0.18). Learn more on analysts' earnings estimate vs. XLO's actual earnings.

Xilio Therapeutics (NASDAQ:XLO) has a recorded annual revenue of $9.27 million.

Xilio Therapeutics (NASDAQ:XLO) has a recorded net income of -$76.40 million. XLO has generated -$0.84 earnings per share over the last four quarters.

Xilio Therapeutics's earnings are expected to grow from ($1.14) per share to ($0.40) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:XLO) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners